BRPI0503734A - pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration - Google Patents
pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administrationInfo
- Publication number
- BRPI0503734A BRPI0503734A BRPI0503734A BRPI0503734A BR PI0503734 A BRPI0503734 A BR PI0503734A BR PI0503734 A BRPI0503734 A BR PI0503734A BR PI0503734 A BRPI0503734 A BR PI0503734A
- Authority
- BR
- Brazil
- Prior art keywords
- morphine
- epidural
- ready
- injection
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA NA FORMA DE SOLUçãO INJETáVEL DE MORFINA PRONTA PARA USO E FORMA DE DOSAGEM UNITáRIA DE MORFINA PARA ADMINISTRAçãO EPIDURAL OU INTRATECAL". A presente invenção refere-se a uma composição analgésica na forma de uma solução injetável, estéril e apirogênica que é constituída de um sal farmaceuticamente aceitável de morfina dissolvido em um solvente (veículo) farmaceuticamente aceitável, sendo o pH da solução resultante na faixa de 2,5 a 6,5 e a concentração de morfina de cerca de 0,025 a 0,195 mg/mL (expressa como o seu sal hidratado). Tal composição, acondicionada em um container selado, é pronta para uso e é adequada para administração epidural e intratecal em adultos e endovenosa em crianças."PHARMACEUTICAL COMPOSITION IN THE FORM OF INJECTABLE MORPHINE READY FOR USE AND UNITARY MORPHINE DOSAGE FORM FOR EPIDURAL OR INTRATECAL ADMINISTRATION". The present invention relates to an analgesic composition in the form of a sterile, pyrogen-free solution for injection which is comprised of a pharmaceutically acceptable salt of morphine dissolved in a pharmaceutically acceptable solvent (carrier), the pH of the resulting solution being in the range of 2 0.5 to 6.5 and the morphine concentration of about 0.025 to 0.195 mg / mL (expressed as its hydrated salt). Such a composition, packaged in a sealed container, is ready for use and is suitable for epidural and intrathecal administration in adults and intravenous in children.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0503734 BRPI0503734A (en) | 2005-08-23 | 2005-08-23 | pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration |
PCT/BR2006/000168 WO2007022609A1 (en) | 2005-08-23 | 2006-08-18 | Pharmaceutical composition of morphine in ready-to-use injectable solution form and single dosage form of morphine for epidural or intrathecal administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0503734 BRPI0503734A (en) | 2005-08-23 | 2005-08-23 | pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0503734A true BRPI0503734A (en) | 2007-04-27 |
Family
ID=37771186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0503734 BRPI0503734A (en) | 2005-08-23 | 2005-08-23 | pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration |
Country Status (2)
Country | Link |
---|---|
BR (1) | BRPI0503734A (en) |
WO (1) | WO2007022609A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9155734B2 (en) * | 2012-03-07 | 2015-10-13 | Mallinckrodt Llc | Stability of hydromorphone hydrochloride solutions |
BR112015021586B1 (en) | 2013-03-14 | 2023-01-31 | Fresenius Kabi Deutschland Gmbh | INJECTABLE PHARMACEUTICAL MORPHINE FORMULATION AND KIT |
EP3424547A1 (en) | 2013-03-14 | 2019-01-09 | Fresenius Kabi Austria GmbH | Packaging system for oxygen-sensitive drugs |
WO2014140899A2 (en) * | 2013-03-15 | 2014-09-18 | Johnson Matthey Public Limited Company | Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4367738A (en) * | 1981-10-28 | 1983-01-11 | Janssen Pharmaceutica Inc. | Pre-filled syringe for abusable drugs |
CA2258965A1 (en) * | 1996-06-28 | 1998-01-08 | Oxigene, Inc. | Useful formulations of acid addition salt drugs |
-
2005
- 2005-08-23 BR BRPI0503734 patent/BRPI0503734A/en not_active Application Discontinuation
-
2006
- 2006-08-18 WO PCT/BR2006/000168 patent/WO2007022609A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007022609B1 (en) | 2007-04-12 |
WO2007022609A1 (en) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171939T1 (en) | Antibody formulation and therapeutic regimens | |
NZ591859A (en) | Peripheral opioid receptor antagonists and uses thereof | |
BRPI0407810A (en) | compound, pharmaceutical composition, glucokinase activator, and medicament | |
CL2011001178A1 (en) | Use of (r) -7-chloro-niquinuclidin-3-1l) senzo [b] thiophene-2-carboxamide or a salt thereof or a pharmaceutical composition comprising it to prepare a useful medication to improve cognition in a patient suffering from Alzheimer's or schizophrenia. | |
BR0013648A (en) | Benzamide derivative-containing pharmaceutical formulation having improved oral solubility and absorption | |
BR112014010590A2 (en) | 18-Methyl-6,7-methylen-3-oxo-17-pregn-4-ene-21,17'-carbolactones, pharmaceutical preparations containing the mentioned compounds and their use in endometriosis therapy | |
BRPI0714055B8 (en) | compounds that modulate pharmacokinetic properties of therapeutics, pharmaceutical compositions comprising said compounds and uses thereof | |
SI2796171T1 (en) | Use of amisulpride for treating opiated-induced nausea and vomiting | |
BRPI0407121B8 (en) | stable pharmaceutical solution to prevent or reduce nausea and vomiting, method of storage and filling the container with said solution | |
BRPI0514091A (en) | Substituted 8-aminoalkylthioxanthines, and their use as dipepetidyl peptidase iv inhibitors | |
BR0111377A (en) | Thiophene derivatives useful as anticancer agents | |
MX2007013583A (en) | Methods and compositions for treating pain. | |
BR112014032695A2 (en) | stable formulations for parenteral injection of small molecule drugs | |
ES2656562T3 (en) | Polymyxin derivative and uses thereof | |
ECSP066477A (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES ACID (2R) -2-PROPYLOCTANOIC AS AN ACTIVE INGREDIENT | |
BRPI0503734A (en) | pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration | |
BR112012006172A2 (en) | Alkyl Oxindole Derivatives and Their Uses for the Treatment of Obesity, Diabetes, and Hyperlipidemia | |
CL2011003046A1 (en) | Pharmaceutical composition comprising 7- (2,5-dihydro-4-imidazo [1,2-a] -pyridin-3-yl-2,5-dioxo-1h-pyrrol-3-yl) -9-fluoro-1 , 2,3,4-tetrahydro-2- (1-piperidinyl-carbonyl) pyrrolo [3,2,1-jk] [1,4] benzodiazepine, a salt or solvate, sbe7-b-cd and optionally a buffer; Preparation process; Useful to treat cancer (div. sol. 1848-08). | |
BR0313727A (en) | Isoquinoline derivatives as matrix metalloproteinase inhibitors | |
BRPI0606119B8 (en) | injectable preparations of diclofenac and its pharmaceutically acceptable salts | |
TN2009000088A1 (en) | Packaging system for pharmaceutical compositions and kit for intravenous administration | |
CO6592023A2 (en) | Pharmaceutical compositions comprising paracetamol and process for preparing it | |
BR112014017656A2 (en) | compound, pharmaceutical composition, and use of a compound | |
BRPI0815595B8 (en) | antifungal composition for oral administration, which is self-emulsifying in contact with an aqueous phase, its use and pharmaceutical product | |
CO6331430A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A KETOROLACO SALT AND VITAMINS OF COMPLEX B FOR THE TREATMENT OF NEURALGIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09B | Decision: refusal | ||
B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |